UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial

Annals of oncology, 2022-10, Vol.33 (10), p.1021-1028

2022

Volltextzugriff (PDF)

Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma

Gynecologic oncology, 2014-02, Vol.132 (2), p.322-327

2014

Volltextzugriff (PDF)

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

Annals of oncology, 2023-12, Vol.34 (12), p.1152-1164

2023

Volltextzugriff (PDF)

Urological outcomes following pelvic exenteration for non-urological malignancies

Heliyon, 2024-04, Vol.10 (8), p.e29640-e29640, Article e29640

2024

Volltextzugriff (PDF)

An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors

Oncogene, 2016-01, Vol.35 (4), p.438-447

2016

Volltextzugriff (PDF)

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

JAMA : the journal of the American Medical Association, 2002-08, Vol.288 (7), p.862

2002

Volltextzugriff (PDF)

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis

Oncogene, 2014-08, Vol.33 (35), p.4424-4432

2014

Volltextzugriff (PDF)

Human Immunodeficiency Virus‐Associated Thrombotic Microangiopathies: Clinical Characteristics and Outcome According to ADAMTS13 Activity

Scandinavian journal of immunology, 2008-09, Vol.68 (3), p.337-344

2008

Volltextzugriff (PDF)

Long-term tolerability of olaparib tablets as maintenance therapy for platinum-sensitive relapsed ovarian cancer (PSR OC): Phase III SOLO2 trial

Annals of oncology, 2018-10, Vol.29, p.viii340-viii341

2018

Volltextzugriff (PDF)

Indications for plasma exchange in systemic lupus erythematosus in 2005

Lupus, 2005-01, Vol.14 (11), p.871-877

2005

Volltextzugriff (PDF)

Bowel obstruction in recurrent gynecologic malignancies: Defining who will benefit from surgical intervention

European journal of surgical oncology, 2014-07, Vol.40 (7), p.899-904

2014

Volltextzugriff (PDF)

Treatment with olaparib monotherapy in the maintenance setting significantly improves progression-free survival in patients with platinum-sensitive relapsed ovarian cancer: Results from the phase III SOLO2 study

Gynecologic oncology, 2017-06, Vol.145, p.219-220

2017

Volltextzugriff (PDF)

Young women with epithelial ovarian cancer: Prevalence of BRCA mutations and clinical correlates

Gynecologic oncology, 2016-06, Vol.141, p.90-90

2016

Volltextzugriff (PDF)

Fertility preservation in young patients with epithelial ovarian tumors of low malignant potential: How does it impact disease outcome?

Gynecologic oncology, 2016-06, Vol.141, p.96-96

2016

Volltextzugriff (PDF)

Requirements for Cannabis Product Labeling by U.S. State

Cannabis and cannabinoid research, 2022-04, Vol.7 (2), p.156-160

2022

Volltextzugriff (PDF)

523 Initial clinical experience with pembrolizumab in metastatic heavily pre-treated patients with solid cancers in a single institution

European journal of cancer (1990), 2015-09, Vol.51, p.S111-S111

2015

Volltextzugriff (PDF)

2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation

European journal of cancer (1990), 2015-09, Vol.51, p.S545-S545

2015

Volltextzugriff (PDF)

2702 Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)

European journal of cancer (1990), 2015-09, Vol.51, p.S532-S532

2015

Volltextzugriff (PDF)

Applications transfusionnelles et thérapeutiques des techniques d'aphérèse

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2002, Vol.9 (3), p.186-228

2002

Volltextzugriff (PDF)

Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy

International journal of gynecological cancer, 2005-03, Vol.15 (2), p.325-328

2005

Volltextzugriff (PDF)

Le don du sang

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2002, Vol.9 (3), p.168-178

2002

Volltextzugriff (PDF)

Les vigilances sanitaires

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2002, Vol.9 (3), p.233-241

2002

Volltextzugriff (PDF)

Principe de la séparation des éléments du sang

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2002, Vol.9 (3), p.179-185

2002

Volltextzugriff (PDF)

MRgFUS for pain relief as palliative treatment in recurrent cervical carcinoma: A case report

Gynecologic oncology, 2008-01, Vol.108 (1), p.241-243

2008

Volltextzugriff (PDF)

Gestion des effets secondaires

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2002, Vol.9 (3), p.242-243

2002

Volltextzugriff (PDF)

1 – 25 von 621

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(543)
Mit Volltextzugriff
(517)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(342)
Life Sciences & Biomedicine
(295)
Animals
(232)
Female
(228)
Mice
(201)
Humans
(187)
Male
(128)
Biological And Medical Sciences
(117)
Mice, Knockout
(110)
Endocrinology & Metabolism
(96)
Receptors, Estrogen - Genetics
(72)
Estrogens
(71)
Fundamental And Applied Biological Sciences. Psychology
(66)
Medical Sciences
(56)
Mice, Inbred C57bl
(56)
Estradiol - Pharmacology
(53)
Estrogen Receptor Alpha - Genetics
(50)
Receptors, Estrogen - Physiology
(49)
Estrogen Receptor Alpha
(47)
Biochemistry & Molecular Biology
(46)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial

Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

Urological outcomes following pelvic exenteration for non-urological malignancies

An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis

Human Immunodeficiency Virus‐Associated Thrombotic Microangiopathies: Clinical Characteristics and Outcome According to ADAMTS13 Activity

Long-term tolerability of olaparib tablets as maintenance therapy for platinum-sensitive relapsed ovarian cancer (PSR OC): Phase III SOLO2 trial

Indications for plasma exchange in systemic lupus erythematosus in 2005

Bowel obstruction in recurrent gynecologic malignancies: Defining who will benefit from surgical intervention

Treatment with olaparib monotherapy in the maintenance setting significantly improves progression-free survival in patients with platinum-sensitive relapsed ovarian cancer: Results from the phase III SOLO2 study

Young women with epithelial ovarian cancer: Prevalence of BRCA mutations and clinical correlates

Fertility preservation in young patients with epithelial ovarian tumors of low malignant potential: How does it impact disease outcome?

Requirements for Cannabis Product Labeling by U.S. State

523 Initial clinical experience with pembrolizumab in metastatic heavily pre-treated patients with solid cancers in a single institution

2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation

2702 Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)

Applications transfusionnelles et thérapeutiques des techniques d'aphérèse

Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy

Le don du sang

Les vigilances sanitaires

Principe de la séparation des éléments du sang

MRgFUS for pain relief as palliative treatment in recurrent cervical carcinoma: A case report

Gestion des effets secondaires

Suchergebnisse filtern